DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neulasta (Pegfilgrastim) - Fatigue - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Fatigue (56)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neulasta (Pegfilgrastim) where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 56   Next >>

Possible Neulasta side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-22

Patient: 67 year old female

Reactions: Fatigue, Nausea, Herpes Zoster

Drug(s) suspected as cause:
Zantac
    Indication: Pruritus

Ebastine
    Dosage: 10 mg, unk
    Indication: Faecaloma

Ebastine
    Indication: Pruritus

Neulasta
    Indication: Pruritus

Zofran
    Dosage: 8 mg, unk
    Indication: Faecaloma
    Start date: 2012-06-26

Halaven
    Dosage: unk
    Indication: Faecaloma
    Start date: 2012-06-19

Halaven
    Dosage: 1.58 mg, unk
    Indication: Pruritus
    Start date: 2012-06-26

Zantac
    Dosage: 50 mg, unk
    Indication: Faecaloma
    Start date: 2012-06-26

Zofran
    Indication: Pruritus

Solu-Medrol
    Dosage: 20 mg, unk
    Indication: Faecaloma
    Start date: 2012-06-26

Loratadine
    Indication: Pruritus

Neulasta
    Dosage: unk
    Indication: Faecaloma

Solu-Medrol
    Indication: Pruritus

Loratadine
    Indication: Faecaloma

Other drugs received by patient: Acebutolol; Nexium



Possible Neulasta side effects in female

Reported by a consumer/non-health professional from France on 2012-08-21

Patient: female

Reactions: Fatigue, Nausea, Herpes Zoster

Drug(s) suspected as cause:
Solu-Medrol
    Dosage: 20 mg/day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Neulasta
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-27

Ebsatine
    Indication: Faecaloma

Loratadine
    Indication: Pruritus

Loratadine
    Indication: Faecaloma

Ebsatine
    Indication: Pruritus

Halaven
    Dosage: 1.58 mg/day
    Start date: 2012-06-26

Halaven
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-19

Zofran
    Dosage: 8 mg/day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Zantac
    Dosage: 50 mg/day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Other drugs received by patient: Acebutolol; Nexium



Possible Neulasta side effects in female

Reported by a physician from France on 2012-08-15

Patient: female

Reactions: Fatigue, Pruritus, Nausea, Faecaloma, Herpes Zoster

Drug(s) suspected as cause:
Ebastine
    Indication: Pruritus

Loratadine
    Indication: Pruritus

Zantac
    Dosage: 50mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Zofran
    Dosage: 8mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Neulasta
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-27

Halaven
    Dosage: 1.58mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Solu-Medrol
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Other drugs received by patient: Cyclophosphamide; Fluorouracil; Methotrexate; Nexium; Bevacizumab; Doxorubicin HCL; Acebutolol



Possible Neulasta side effects in female

Reported by a physician from United States on 2012-08-13

Patient: female, weighing 37.1 kg (81.6 pounds)

Reactions: Fatigue, Body Temperature Increased, Hypophagia, Heart Rate Increased, Oropharyngeal Pain, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg
    End date: 2012-07-27

Neulasta
    Dosage: 6 mg
    End date: 2012-07-28

Doxorubicin HCL
    Dosage: 100 mg
    End date: 2012-07-27



Possible Neulasta side effects in 67 year old female

Reported by a physician from France on 2012-08-08

Patient: 67 year old female

Reactions: Fatigue, Nausea, Herpes Zoster

Drug(s) suspected as cause:
Neulasta
    Dosage: unk
    Indication: Chemotherapy
    Start date: 2012-06-27

Halaven
    Dosage: 1.58 mg, unk
    Start date: 2012-06-19

Ondansetron
    Dosage: 8 mg, unk
    Start date: 2012-06-26

Solu-Medrol
    Dosage: 20 mg, unk
    Start date: 2012-06-26

Zantac
    Dosage: 50 mg, unk
    Start date: 2012-06-26



Possible Neulasta side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-02

Patient: 71 year old female, weighing 74.0 kg (162.8 pounds)

Reactions: Fatigue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1020 mg, q3wk
    Indication: Breast Cancer
    Start date: 2009-12-09
    End date: 2010-01-27

Neulasta
    Dosage: 6 mg, q3wk
    Indication: Premedication
    Start date: 2009-12-09
    End date: 2010-01-27

Neulasta
    Indication: Colony Stimulating Factor Prophylaxis

Taxotere
    Dosage: 128 mg, q3wk
    Indication: Breast Cancer
    Start date: 2009-12-09
    End date: 2010-01-27

Other drugs received by patient: Dexamethasone; Aloxi; Mesna; Dexamethasone



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28

Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)

Reactions: Dyspnoea, Chest Discomfort, Fatigue, Chest Pain, Sensation of Pressure

Drug(s) suspected as cause:
Neulasta
    Dosage: 6 mg milligram(s) subcutaneous
    Indication: Chemotherapy

Ranitidine
    Dosage: 50 mg milligram(s), intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

(Domperidone)
    Dosage: 20 mg milligram(s), 1 day, oral ; 20 mg, as needed
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg milligram(s) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg milligram(s), intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Chlorpheniramine Maleate
    Dosage: 10 mg milligram(s) intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    End date: 2011-07-05

Other drugs received by patient: (Docusate); (Biotene / 00203502 / )



Possible Neulasta side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-25

Patient: female

Reactions: Pain, non-Alcoholic Steatohepatitis, Weight Increased, Anticoagulant Therapy, Fatigue, Fibromyalgia, Central Venous Catheterisation, Oedema Peripheral, Depression, Migraine, Back Pain, Pain in Extremity, Therapeutic Product Ineffective, Menopause, Hysterectomy, Swelling, Alopecia, Disability, Deep Vein Thrombosis, Mobility Decreased

Drug(s) suspected as cause:
Neulasta

Other drugs received by patient: Chemotherapeutics



Possible Neulasta side effects in female

Reported by a physician from United States on 2012-06-25

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Fatigue, Vomiting, Herpes Simplex, Bone Pain, Mucosal Dryness, Headache, Constipation, Hyperhidrosis, Decreased Appetite

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2011-12-28
    End date: 2012-03-01

Taxotere
    Indication: Breast Cancer
    Start date: 2011-12-28
    End date: 2012-03-01

Neulasta
    Indication: Chemotherapy
    Start date: 2011-12-29

Other drugs received by patient: Sipralexa / 01588501 /; Colecalciferol; Simvastatin



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Chest Discomfort, Dyspnoea, Fatigue

Drug(s) suspected as cause:
Neulasta
    Indication: Chemotherapy

Granisetron
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone

Domperidone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    End date: 2011-07-05

Ranitidine
    Indication: Product Used FOR Unknown Indication

Chlorpheniramine TAB
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Dexamethasone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Cyclophosphamide; Docusate; Doxorubicin HCL; Biotene



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-01

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Chest Discomfort, Fatigue, Dyspnoea, Chest Pain

Adverse event resulted in: death

Drug(s) suspected as cause:
Ranitidine
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Domperidone
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone
    Dosage: unk
    Administration route: Oral

Chlorpheniramine TAB
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral

Dexamethasone
    Dosage: unk

Paclitaxel
    Dosage: 300 mg, 1/2 weeks
    End date: 2011-07-05

Neulasta
    Indication: Chemotherapy

Dexamethasone
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Pegfilgrastim
    Dosage: unk
    Indication: Chemotherapy

Granisetron
    Dosage: 1 mg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315 mg, 1/2 weeks
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Other drugs received by patient: Docusate; Biotene DRY Mouth



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Fatigue, Dyspnoea, Chest Pain, Obstructive Airways Disorder, Sensation of Pressure

Drug(s) suspected as cause:
Neulasta
    Dosage: 6 mg, unk, sc
    Indication: Chemotherapy

Dexamethasone
    Dosage: 4 mg, bid, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg, bid, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone (Domperidone)
    Dosage: 20 mg, unk, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Chlorpheniramine Maleate
    Dosage: 10 mg, unk, iv
    Indication: Product Used FOR Unknown Indication

Dexamethasone Sodium Phosphate
    Dosage: 20 mg, unk, iv
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315;300 mg, unk, iv
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-06-07

Paclitaxel
    Dosage: 315;300 mg, unk, iv
    Indication: Breast Cancer
    Start date: 2011-06-21
    End date: 2011-07-05

Ranitidine
    Dosage: 50 mg, unk, iv

Other drugs received by patient: Biotene; Docusate



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30

Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)

Reactions: Dyspnoea, Fatigue, Chest Discomfort, Hypopnoea, Chest Pain

Drug(s) suspected as cause:
Ranitidine
    Dosage: 50 mg milligram(s), intravenous
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg milligram(s) (1 day), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

(Chlorphenamine)
    Dosage: 10 mg milligram(s), intravenous
    Indication: Product Used FOR Unknown Indication

Neulasta
    Dosage: 6 mg milligram(s), subcutaneous
    Indication: Chemotherapy

Dexamethasone
    Dosage: 20 mg milligram(s), intravenous
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-05

Paclitaxel
    Dosage: 315 mg milligram(s) (2 week), intravenous
    Indication: Breast Cancer
    End date: 2011-07-05

Paclitaxel
    Dosage: 315 mg milligram(s) (2 week), intravenous
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

(Domperidone)
    Dosage: 20 mg milligram(s), 1 day, oral, 20 mg, as needed, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg milligram(s) (1 day), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: (Biotene); Docusate



Possible Neulasta side effects in 77 year old male

Reported by a physician from Denmark on 2012-05-29

Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)

Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Neulasta
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-26

Prednisolone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Cyclophosphamide
    Dosage: 1612 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Other drugs received by patient: Pinex; Sulphamethizole; Valacyclovir Hydrochloride; Omeprazole



Possible Neulasta side effects in 48 year old female

Reported by a pharmacist from United Kingdom on 2012-05-29

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Chest Discomfort, Fatigue, Dyspnoea, Chest Pain

Drug(s) suspected as cause:
Neulasta
    Dosage: 6 mg, unk
    Indication: Chemotherapy

Paclitaxel
    Dosage: 315 mg, q2wk
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-06-07

Motilium
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 300 mg, q2wk
    Start date: 2011-06-21
    End date: 2011-07-05

Ranitidine
    Dosage: 50 mg, unk
    Indication: Product Used FOR Unknown Indication

Chlorpheniramine TAB
    Dosage: 10 mg, unk
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral

Dexamethasone
    Dosage: 20 mg, bid
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Docusate; Biotene / 06680101 /



Possible Neulasta side effects in 48 year old female

Reported by a physician from United Kingdom on 2012-05-23

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Chest Discomfort, Fatigue, Dyspnoea, Chest Pain

Drug(s) suspected as cause:
Chlorpheniramine TAB
    Indication: Product Used FOR Unknown Indication

Ranitidine
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 8mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone
    Administration route: Oral

Paclitaxel
    Dosage: 300mg every two weeks
    Start date: 2011-06-21
    End date: 2011-07-05

Dexamethasone

Granisetron
    Dosage: 2mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315mg every two weeks
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-06-07

Neulasta
    Indication: Chemotherapy

Other drugs received by patient: Biotene DRY Mouth Mouthwash; Docusate



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-22

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Dyspnoea, Chest Discomfort, Fatigue, Chest Pain

Drug(s) suspected as cause:
Chlorpheniramine TAB
    Dosage: 10 mg, unk
    Indication: Product Used FOR Unknown Indication

Neulasta
    Dosage: 6 mg, unk
    Indication: Chemotherapy

Paclitaxel
    Dosage: 300 mg, q2wk
    End date: 2011-07-05

Dexamethasone
    Dosage: 20 mg, unk
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315 mg, unk
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Dexamethasone
    Dosage: 4 mg, unk
    Administration route: Oral

Ranitidine
    Dosage: 50 mg, unk
    Indication: Product Used FOR Unknown Indication

Domperidone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Biotene / 06680101 /; Docusate



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-16

Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)

Reactions: Respiratory Depth Decreased, Product Substitution Issue, Dyspnoea, Fatigue, Chest Discomfort, Chest Pain, Obstructive Airways Disorder, Discomfort

Drug(s) suspected as cause:
Granisetron
    Dosage: 1 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone
    Dosage: 20 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ranitidine
    Dosage: 50mg milligram(s), intravenous
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg milligram(s), intravenous
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Neulasta
    Dosage: 6 mg milligram(s), subcutaneous
    Indication: Chemotherapy

Chlorpheniramine TAB
    Dosage: 10 mg (milligram(s), intravenous
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315 mg milligram(s), intravenous
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-06-07

Other drugs received by patient: Docusate; Biotene



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-14

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Chest Discomfort, Fatigue, Dyspnoea

Adverse event resulted in: death

Drug(s) suspected as cause:
Domperidone
    Administration route: Oral

Chlorpheniramine TAB
    Indication: Product Used FOR Unknown Indication

Pegfilgrastim
    Indication: Chemotherapy

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral

Domperidone
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: unk
    Indication: Breast Cancer
    Start date: 2011-06-21
    End date: 2011-07-05

Paclitaxel
    Dosage: unk
    Start date: 2011-05-24
    End date: 2011-07-05

Ranitidine
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315 mg every 2 weeks
    Start date: 2011-05-24
    End date: 2011-06-07

Neulasta
    Indication: Chemotherapy

Other drugs received by patient: Docusate; Biotene DRY Mouth



Possible Neulasta side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-11

Patient: female

Reactions: Fatigue, Pain

Drug(s) suspected as cause:
Tykerb
    Dosage: 1250mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-13

Neulasta
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-14



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Fatigue, Chest Discomfort, Dyspnoea

Drug(s) suspected as cause:
Neulasta
    Indication: Chemotherapy

Chlorpheniramine TAB
    Indication: Product Used FOR Unknown Indication

Domperidone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ranitidine
    Indication: Product Used FOR Unknown Indication

Granisetron
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Other drugs received by patient: Doxorubicin HCL; Docusate; Cyclophosphamide; Biotene



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10

Patient: 48 year old female

Reactions: Chest Discomfort, Fatigue, Dyspnoea

Drug(s) suspected as cause:
Chlorpheniramine TAB
    Dosage: 10 mg; ;iv
    Indication: Product Used FOR Unknown Indication

Neulasta
    Dosage: 6 mg; sc
    Indication: Chemotherapy

Dexamethasone Sodium Phosphate
    Dosage: 20 mg; ;iv
    Indication: Product Used FOR Unknown Indication

Domperidone (Domperidone)
    Dosage: 20 mg; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ranitidine
    Dosage: 50 mg; iv
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315 mg; ;iv, 300 mg;iv
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-06-07

Other drugs received by patient: Docusate; Biotene - / 00203502 /



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Dyspnoea, Fatigue, Chest Discomfort, Chest Pain

Drug(s) suspected as cause:
Domperidone (Domperidone)
    Dosage: 20 mg;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315 mg;iv ; 300 mg;iv
    Indication: Breast Cancer
    Start date: 2011-06-21
    End date: 2011-07-05

Paclitaxel
    Dosage: 315 mg;iv ; 300 mg;iv
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-06-07

Dexamethasone Sodium Phosphate
    Dosage: 20 mg;iv
    Indication: Product Used FOR Unknown Indication

Neulasta
    Dosage: 6 mg;sc
    Indication: Chemotherapy

Granisetron
    Dosage: 1 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ranitidine
    Dosage: 50 mg;iv
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Chlorpheniramine Maleate
    Dosage: 10 mg;iv
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Docusate; Biotene / 00203502 /



Possible Neulasta side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Dyspnoea, Chest Discomfort, Fatigue

Drug(s) suspected as cause:
Domperidone
    Dosage: 20 mg, unk
    Administration route: Oral

Chlorpheniramine Maleate
    Dosage: 10 mg, unk

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral

Granisetron
    Dosage: 1 mg, unk
    Administration route: Oral

Neulasta
    Dosage: 6 mg, unk
    Indication: Chemotherapy

Paclitaxel
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Ranitidine
    Dosage: 50 mg, unk

Other drugs received by patient: Biotene; Docusate



Possible Neulasta side effects in 48 year old female

Reported by a pharmacist from United Kingdom on 2012-05-03

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Fatigue, Dyspnoea, Chest Discomfort

Drug(s) suspected as cause:
Ranitidine
    Indication: Product Used FOR Unknown Indication

Neulasta
    Indication: Chemotherapy

Granisetron
    Dosage: 2mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 8mg per day
    Administration route: Oral

Domperidone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Start date: 2011-06-21
    End date: 2011-07-05

Chlorpheniramine Maleate
    Indication: Product Used FOR Unknown Indication

Domperidone
    Administration route: Oral

Dexamethasone
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-06-07

Other drugs received by patient: Docusate; Biotene DRY Mouth Mouthwash



Possible Neulasta side effects in 77 year old male

Reported by a physician from Denmark on 2012-04-26

Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)

Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Cyclophosphamide
    Dosage: 1612 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Prednisolone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Neulasta
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-26

Other drugs received by patient: Sulphamethizole; Omeprazole; Pinex; Valacyclovir Hydrochloride



Possible Neulasta side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-20

Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)

Reactions: Anaemia, Pyrexia, Dyspnoea Exertional, Fatigue, Sepsis, Chest Pain, Thrombocytopenia, Myocardial Infarction, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Dosage: 100 mg
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-29

Neulasta
    Dosage: 6 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-02

Vincristine
    Dosage: 2 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Cyclophosphamide
    Dosage: 1410 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Gemcitabine
    Dosage: 1880 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-01

Rituximab
    Dosage: 705 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Other drugs received by patient: Metoclopramide; Cotrim; Aspirin; Tramadol HCL



Possible Neulasta side effects in 77 year old male

Reported by a physician from Denmark on 2012-04-19

Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)

Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Febrile Neutropenia, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Prednisone TAB
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Cyclophosphamide
    Dosage: 1612 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Neulasta
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-26

Other drugs received by patient: Pinex; Omeprazole; Valacyclovir Hydrochloride; Sulphamethizole



Possible Neulasta side effects in 48 year old female

Reported by a pharmacist from United Kingdom on 2012-04-12

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Fatigue, Chest Discomfort, Dyspnoea

Drug(s) suspected as cause:
Neulasta
    Indication: Chemotherapy

Ranitidine
    Dosage: 50 mg, unk
    Indication: Product Used FOR Unknown Indication

Chlorpheniramine Maleate
    Dosage: 10 mg, unk
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: unk mg, unk
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Domperidone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: unk unk, bid
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Biotene / 06680101 /; Docusate



Possible Neulasta side effects in female

Reported by a pharmacist from Ireland on 2012-04-05

Patient: female

Reactions: Back Pain, Abdominal Discomfort, Fatigue, Nausea, Oral Infection, Bone Pain, Pharyngitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta

Other drugs received by patient: Docetaxel; Losec / 00661201 /; Zofran; KIN; Dexamethasone; Cyclophosphamide; Mycostatin; Valoid / 00014902 /



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017